Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Amplification status of GAS41 and MDM2 in adenocarcinomas
EF 2009-10
Résumé
Lung cancer is the number one cause of cancer death worldwide. High mortality rates are attributed to poor therapeutic strategies and a lack of screening for early detection. A greater understanding of lung cancer biology is therefore needed to identify new gene targets with the potential of improving treatment of lung cancer. My preliminary data show that the dosage of two genes on chromosome 12, GAS41 and MDM2 are frequently increased in lung cancer. My project will focus on the functional consequences of co-amplification of these genes, and establish the importance of this occurrence to survival. Amplification of this gene region has also been observed in a variety of cancers including brain, bone and breast. Based on the physiologic roles of these genes, we believe that co-amplification will have an additive effect that drives disease progression and results in poor prognosis. To assess the effect and frequency of amplification, I will analyze for gene disruption in clinical specimens as well as demonstrate the biological effects in cultured cells. Ultimately, this research will provide insight into a novel mechanism of lung cancer development. In addition, it will tell us whether GAS41 and MDM2 are worthy of further investigation as a prognostic biomarker or as a target for developing novel lung cancer therapeutics.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
201557
Name
Pikor Larissa
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Amplification status of GAS41 and MDM2 in adenocarcinomas
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
12q13-15; Co-Amplification; Gas41; Gene Expression; Lung Cancer; Mdm2; P53; Tumorigenesis
Abstract
Lung cancer is the number one cause of cancer death worldwide. High mortality rates are attributed to poor therapeutic strategies and a lack of screening for early detection. A greater understanding of lung cancer biology is therefore needed to identify new gene targets with the potential of improving treatment of lung cancer. My preliminary data show that the dosage of two genes on chromosome 12, GAS41 and MDM2 are frequently increased in lung cancer. My project will focus on the functional consequences of co-amplification of these genes, and establish the importance of this occurrence to survival. Amplification of this gene region has also been observed in a variety of cancers including brain, bone and breast. Based on the physiologic roles of these genes, we believe that co-amplification will have an additive effect that drives disease progression and results in poor prognosis. To assess the effect and frequency of amplification, I will analyze for gene disruption in clinical specimens as well as demonstrate the biological effects in cultured cells. Ultimately, this research will provide insight into a novel mechanism of lung cancer development. In addition, it will tell us whether GAS41 and MDM2 are worthy of further investigation as a prognostic biomarker or as a target for developing novel lung cancer therapeutics.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pikor, Larissa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~